COLUMBIA, Md., July 28 Martek Biosciences Corporation (Nasdaq: MATK) announced today that it will be presenting at the Canaccord Adams 29th Annual Global Growth Conference which is scheduled to take place August 11-13, 2009 at the InterContinental Boston Hotel in Boston, MA. Steve Dubin, Chief Executive Officer, and Peter L. Buzy, Chief Financial Officer, are scheduled to present on Tuesday, August 11, 2009, at 3:00 p.m. Eastern Time.
Advertisement
A live audio webcast of Martek's presentation can be accessed at:
http://www.wsw.com/webcast/canaccord/matk/
Martek Biosciences Corporation is a leader in the innovation and development of omega-3 DHA products that promote health and wellness through every stage of life. The Company produces life'sDHA(TM), a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, infant formula and supplements, and life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com.
Contact: Kyle Stults Investor Relations (410) 740-0081
SOURCE Martek Biosciences Corporation
